For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Servier Pharmaceuticals LLC

USPTO Granted Patents = 21

Trademarks = 9

Forward Citations = 8

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Jeremy Mark Travins (7 out of 52 patents)

Chong-Hui Gu (5 out of 19 patents)

Zenon D Konteatis (5 out of 14 patents)

4. Janeta Popovici-Muller (5 out of 45 patents)

5. Zhihua Sui (3 out of 108 patents)

6. Ding Zhou (3 out of 22 patents)

7. Zhenwei Cai (3 out of 20 patents)

8. Shijie Zhang (3 out of 39 patents)

9. Jacob Paul Sizemore (3 out of 3 patents)

10. Robert Zahler (2 out of 74 patents)

11. Benjamin S Lane (2 out of 8 patents)

12. Nelamangala Nagaraja (2 out of 4 patents)

13. Joshua Murtie (2 out of 4 patents)

14. Brandon Nicolay (2 out of 4 patents)

15. David Schenkein (2 out of 7 patents)

21 patents: Sort by Forward Citations

1. 12479824 - Method for preparing ivosidenib and an intermediate thereof (2025-11-25),

2. 12433895 - Therapeutically active compounds and their methods of use (2025-10-07),

3. 12303512 - Therapeutically active compounds and their methods of use (2025-05-20),

4. 12297179 - Crystalline and salt forms of an organic compound and pharmaceutical compositions thereof (2025-05-13),

5. 12290508 - Methods of use for trisubstituted benzotriazole derivatives (2025-05-06),

6. 12264148 - Ivosidenib forms and pharmaceutical compositions (2025-04-01),

7. 12064436 - Methods of treating brain tumors using combination therapy (2024-08-20),

8. 12042497 - Methods of treating brain tumors using combination therapy (2024-07-23),

9. RE49934 - Inhibitors of cellular metabolic processes (2024-04-23),

10. 11865079 - Therapeutically active compounds and their methods of use (2024-01-09),

11. 11851417 - Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same (2023-12-26),

12. 11844758 - Therapeutically active compounds and their methods of use (2023-12-19),

13. 11717512 - Methods of use for trisubstituted benzotriazole derivatives (2023-08-08),

14. 11667673 - Therapeutically active compounds and their methods of use (2023-06-06),

15. 11524960 - Heterobicyclic inhibitors of MAT2A and methods of use for treating cancer (2022-12-13),

Servier Pharmaceuticals LLC is a commercial-stage biopharmaceutical company with a mission to deliver innovative therapies that improve patient outcomes. With a focus on cardiology, oncology, and diabetes, Servier is committed to advancing healthcare through research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

21 Patents

#115 in Boston, MA

#903 in Massachusetts

#15,156 in US

#29,052 in the World

Boston, MA, United States of America

Servier Pharmaceuticals LLC

Forward Citations = 8

42 inventors:

Jeremy Mark Travins (7 out of 52 patents)

Chong-Hui Gu (5 out of 19 patents)

Zenon D Konteatis (5 out of 14 patents)

4. Janeta Popovici-Muller (5 out of 45 patents)

5. Zhihua Sui (3 out of 108 patents)

Please report any incorrect information to support@idiyas.com

Loading…